Health Condition 1: G408- Other epilepsy and recurrent seizures
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Children under 18 years of age requiring sedative agents for investigation purposes
Exclusion criteria
Exclusion criteria: Patients requiring mechanical ventilation and intravenous inotropic support and those with cyanotic CHD, second- and third-degree heart. Children with muscular dystrophies, multiple congenital anomalies, hepatic or renal dysfunction, and allergy to any of the used drugs were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate and compare the effect of sedation by dexmedetomidine, midazolam, ketamine in a group of children.Timepoint: To evaluate and compare the effect of sedation by dexmedetomidine, midazolam, ketamine in a group of children under 10 years of age , for a period of 24 hours post sedations | — |
Secondary
| Measure | Time frame |
|---|---|
| TO COMPARE THE EFFECTS OF KETAMINE, MIDAZOLAM, DEXMEDETOMIDINE ON THE DURATION OF SEDATIONTimepoint: TO COMPARE THE EFFECTS OF KETAMINE, MIDAZOLAM, DEXMEDETOMIDINE ON THE DURATION OF SEDATION AND ADVERSE EVENTS THAT OCCUR WITHIN 24 HOURS AFTER SEDATION | — |
Countries
India
Contacts
CHETTINA HOSPITAL AND RESEARCH INSTITUTE